Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Acq. announced Inv. presentation Quarterly results
|
Furiex Pharmaceuticals, Inc. (FURX)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
09/18/2013 |
4/A
| McIntyre Gail Frances (Senior Vice President-Research) has filed a Form 4 on Furiex Pharmaceuticals, Inc. |
09/18/2013 |
4/A
| CORR PETER B (Director) has filed a Form 4 on Furiex Pharmaceuticals, Inc.
Txns:
| Exercised 3,600 shares
@ $9.11, valued at
$32.8k
Exercised 1,000 shares
@ $9.11, valued at
$9.1k
|
|
03/14/2013 |
4/A
| Kaldor Stephen W (Director) has filed a Form 4 on Furiex Pharmaceuticals, Inc. |
03/14/2013 |
4/A
| Ruscher Robert P (Director) has filed a Form 4 on Furiex Pharmaceuticals, Inc.
Txns:
| Sold 23,565 shares
@ $41.74, valued at
$983.6k
Sold 4,262 shares
@ $40.71, valued at
$173.5k
Sold 7,243 shares
@ $39.96, valued at
$289.4k
Exercised 5,930 options to buy
@ $13.45, valued at
$79.8k
Exercised 5,829 options to buy
@ $13.94, valued at
$81.3k
Exercised 11,806 options to buy
@ $9.11, valued at
$107.6k
Exercised 1,073 options to buy
@ $13.45, valued at
$14.4k
Exercised 1,054 options to buy
@ $13.94, valued at
$14.7k
Exercised 2,135 options to buy
@ $9.11, valued at
$19.4k
Exercised 1,822 options to buy
@ $13.45, valued at
$24.5k
Exercised 1,792 options to buy
@ $13.94, valued at
$25k
|
|
04/11/2012 |
4/A
| Almenoff June Sherie (President) has filed a Form 4 on Furiex Pharmaceuticals, Inc. |
03/15/2012 |
4/A
| ESHELMAN FREDRIC N (10% Owner) has filed a Form 4 on Furiex Pharmaceuticals, Inc.
Txns:
| Bought 75,000 shares
@ $21.75, valued at
$1.6M
|
|
12/07/2011 |
4/A
| Kaldor Stephen W (Director) has filed a Form 4 on Furiex Pharmaceuticals, Inc. |
12/07/2011 |
4/A
| CORR PETER B (Director) has filed a Form 4 on Furiex Pharmaceuticals, Inc.
Txns:
| Granted 8,825 options to buy
@ $13.45, valued at
$118.7k
|
|
12/07/2011 |
4/A
| DIXON WENDY L (Director) has filed a Form 4 on Furiex Pharmaceuticals, Inc.
Txns:
| Granted 8,825 options to buy
@ $13.45, valued at
$118.7k
|
|
12/07/2011 |
4/A
| Ruscher Robert P (Director) has filed a Form 4 on Furiex Pharmaceuticals, Inc.
Txns:
| Granted 8,825 options to buy
@ $13.45, valued at
$118.7k
|
|
12/07/2011 |
4/A
| BONDURANT STUART (Director) has filed a Form 4 on Furiex Pharmaceuticals, Inc.
Txns:
| Granted 8,825 options to buy
@ $13.45, valued at
$118.7k
|
|
|
|